Literature DB >> 12390961

Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective.

Peter B Berger1, Steven Steinhubl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390961     DOI: 10.1161/01.cir.0000035924.70846.20

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR).

Authors:  L Součková; R Opatřilová; P Suk; I Čundrle; M Pavlík; V Zvoníček; O Hlinomaz; V Šrámek
Journal:  Eur J Clin Pharmacol       Date:  2012-08-14       Impact factor: 2.953

Review 2.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28

Review 3.  Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.

Authors:  S J Walsh; M S Spence; D Crossman; A A J Adgey
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

4.  Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.

Authors:  David Fitchett; John Eikelboom; Stephen Fremes; David Mazer; Steve Singh; Bindu Bittira; Stephanie Brister; John J Graham; Milan Gupta; Keyvan Karkouti; Agnes Lee; Michael Love; Rod McArthur; Mark Peterson; Subodh Verma; Terrence M Yau
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

Review 5.  Management of coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Sundararajan Srikanth; Prakash Deedwania
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

Review 6.  Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines.

Authors:  J Hoekstra; M Cohen
Journal:  Int J Clin Pract       Date:  2009-02-13       Impact factor: 2.503

7.  Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study.

Authors:  Joanna J Wykrzykowska; Ascan Warnholtz; Peter de Jaeger; Nick Curzen; Keith G Oldroyd; Jean Philippe Collet; Jurrien M Ten Berg; Tessa Rademaker; Dick Goedhart; Jurgen Lissens; Peter-Paul Kint; Patrick W Serruys
Journal:  J Thromb Thrombolysis       Date:  2009-11       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.